• Protein A/G Magnetic Beads: Technical Guide and Best Practic

  2026-05-06

  Protein A/G Magnetic Beads (SKU K1305) address the need for efficient and specific antibody purification and protein interaction analysis from complex biological samples. They are best suited to immunoprecipitation, co-IP, and chromatin IP workflows requiring low background and high reproducibility. These beads are not recommended for diagnostic or therapeutic use, nor for workflows requiring binding outside IgG Fc regions.

• Alda 1: ALDH2 Activator Workflows for Cardiac and Dermatitis

  2026-05-06

  Alda 1 empowers researchers to target aldehyde dehydrogenase 2 (ALDH2) activity in both cardiac regeneration and radiation-induced skin injury models. Unlock robust, reproducible data in cardioprotection and aldehyde detoxification assays with protocol-driven insights and troubleshooting strategies.

• Amt-1: Dual Antiviral and Immunomodulatory Mechanisms Agains

  2026-05-05

  This study introduces Amt-1, a novel amantadine derivative, as a potent dual-action antiviral against influenza A virus (IAV). Amt-1 uniquely combines residual M2 ion channel inhibition with activation of the Nrf2/HO-1 pathway, reducing both viral replication and host inflammation—addressing drug resistance limitations of previous adamantane agents.

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-05-05

  HyperScript™ Reverse Transcriptase from APExBIO empowers researchers to achieve high-fidelity cDNA synthesis from challenging RNA templates, including those with complex secondary structures or low abundance. Its engineered thermal stability and reduced RNase H activity ensure robust performance in demanding qPCR and transcriptomics workflows.

• Anti Reverse Cap Analog: Boosting mRNA Translation Efficienc

  2026-05-04

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, revolutionizes synthetic mRNA workflows with orientation-specific capping, doubling translational efficiency in vitro. Its unique chemistry empowers robust mRNA therapeutics research, cell reprogramming, and gene expression studies with unmatched reliability and protein yield.

• GS-441524 Prodrug: Applied Workflows and Antiviral Research

  2026-05-04

  Harness the full potential of GS-441524 in cutting-edge antiviral research with validated workflows and troubleshooting strategies. This article translates recent LC–MS/MS insights and APExBIO product specifications into actionable protocols for pharmacokinetic and conversion pathway studies.

• Optimizing Cancer Research Assays Using 10074-G5 (SKU C5722)

  2026-05-03

  This article delivers scenario-driven guidance for using 10074-G5 (SKU C5722), a validated c-Myc inhibitor, in advanced cancer research workflows. Drawing from real laboratory challenges, it demonstrates how 10074-G5 enhances cell viability, apoptosis, and tumor regression studies with reproducible, data-backed performance. Researchers are equipped with evidence, protocol tips, and vendor selection advice to ensure robust experimental outcomes.

• Z-WEHD-FMK: Irreversible Caspase Inhibitor for Inflammation

  2026-05-02

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) is a potent, cell-permeable, and irreversible inhibitor targeting caspase-1, -4, and -5. It enables precise dissection of caspase-dependent pathways in inflammation and apoptosis assays. APExBIO’s product supports advanced research in infectious disease and cell biology.

• Annexin V: Translating Phosphatidylserine Recognition Into P

  2026-05-02

  This thought-leadership article explores how the molecular mechanism of Annexin V-phosphatidylserine interaction is transforming apoptosis detection and translational cell death research. By integrating recent mechanistic insights and advanced workflow strategies, the discussion bridges foundational biochemistry with strategic guidance for researchers seeking robust, reproducible apoptosis assays. Uniquely, this piece not only synthesizes the latest literature but also benchmarks APExBIO’s human recombinant Annexin V against the evolving competitive landscape, providing actionable protocol parameters and a forward-looking perspective on its future in disease modeling and therapeutic innovation.

• Simvastatin (Zocor) in Cancer and Lipid Research: Workflows

  2026-05-01

  Simvastatin (Zocor) extends beyond cholesterol management, enabling precise workflows in cancer and cardiovascular research. Discover practical protocols, troubleshooting insights, and the latest advances—including its novel autophagy-inducing action in tumor models—for robust, reproducible results.

• FerroOrange: Precision Fe²⁺ Fluorescent Probe for Live-Cell

  2026-04-30

  FerroOrange unlocks real-time, highly specific detection of intracellular Fe²⁺ in living cells—enabling advanced study of neurodegeneration, ferroptosis, and iron metabolism. This guide details stepwise workflows, comparative advantages, and expert troubleshooting for maximizing the probe’s performance in live-cell imaging, flow cytometry, and plate-based assays.

• Filipin III: Precision Cholesterol Detection in Membrane Stu

  2026-04-30

  Filipin III enables high-sensitivity, fluorescence-based cholesterol detection in membranes, surpassing conventional probes for visualization and quantification. Its specificity for cholesterol-rich microdomains empowers researchers to resolve subtle changes in membrane architecture linked to cellular metabolism and disease.

• Applied Scenario Solutions with Minocycline HCl (SKU B1791)

  2026-04-29

  This article delivers scenario-driven guidance for optimizing cell viability and cytotoxicity assays using Minocycline HCl (SKU B1791). Drawing on quantitative data and workflow best practices, we address real laboratory challenges—highlighting how APExBIO’s Minocycline HCl empowers reliable, reproducible, and translational research in inflammation and neurodegeneration.

• Lisinopril Dihydrate in Translational Research: Mechanisms a

  2026-04-29

  Explore how Lisinopril dihydrate, a potent ACE inhibitor, enables advanced translational research beyond standard hypertension models. This article uniquely bridges assay selection, mechanistic insights, and the latest reference findings to empower next-generation cardiovascular and renal studies.

• Fenipentol for Pancreatic and Hepatobiliary Secretion Resear

  2026-04-28

  Fenipentol (1-Phenyl-1-pentanol) stands out as a robust modulator of digestive secretions and estrogen receptor pathways, offering unique advantages in gastrointestinal and hepatobiliary research. This guide details stepwise workflows, data-driven troubleshooting, and experimental insights for maximizing reproducibility with APExBIO's Fenipentol.

450 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page